(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PLEXISION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PLEXISION

ST13

US500000085891733

Class

10, 44

Filing

85891733

Registration

4898906

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

02/09/2025

Trademark type

Word

Nice classes

10, 44

Filing date

04/01/2013

Registration date

02/09/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/18/2022

Last transaction

02/09/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/20/2008

First use in commerce

02/20/2008

Drawing code

4

Owner type

03

Owner location

Pittsburgh, PA

Examiner

SNAPP, TINA

Law office

M70

Current location

TMO LAW OFFICE 116

Holders and representatives

Holders

PLEXISION, INC.

Representatives

ARLEN L. OLSEN SCHMEISER, OLSEN & WATTS, LLP

Technical classification

Nice Classes

Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medicaldiagnostic test kits consisting primarily of probesbuffers and reagentsbiologicalchemicalbiochemicalcellprotein reagents for characterization of cellsgenes and proteins and their functionto determine immune responsefor use to measure immune responsedisease severity and response to therapyfor use in immunological diseasestransplant rejection including stem cells and bone marrowinfectious diseasesautoimmune and genetic diseasesdevelopmental disorders and cancer

Class 44

Medical diagnostic servicesincluding testingmonitoring and reporting services related tocharacterization of cellsgenes and proteins and their function to determine immune responsein healthin immunological diseasestransplant rejectioninfectious diseasesautoimmune and genetic diseasesdevelopmental disorders and cancerfor use to measure immune responsedisease severity and response to therapy

Publications

History of USPTO decisions and trademark events.

42 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/09/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/18/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/18/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/16/2022

E815

TEAS SECTION 8 & 15 RECEIVED

02/08/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/09/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

02/09/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/07/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/04/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/04/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/30/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/03/2015

GNRT

NON-FINAL ACTION E-MAILED

06/03/2015

CNRT

SU - NON-FINAL ACTION - WRITTEN

06/03/2015

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/17/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/15/2015

IUAF

USE AMENDMENT FILED

04/14/2015

EISU

TEAS STATEMENT OF USE RECEIVED

04/14/2015

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/14/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/19/2014

PUBO

PUBLISHED FOR OPPOSITION

08/19/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/30/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/12/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/12/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

07/12/2014

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/12/2014

GNEA

EXAMINERS AMENDMENT E-MAILED

07/12/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/12/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/10/2014

GNRT

NON-FINAL ACTION E-MAILED

03/10/2014

CNRT

NON-FINAL ACTION WRITTEN

03/10/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/06/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/06/2014

ALIE

ASSIGNED TO LIE

01/29/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/21/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/21/2013

GNRT

NON-FINAL ACTION E-MAILED

07/21/2013

CNRT

NON-FINAL ACTION WRITTEN

07/21/2013

DOCK

ASSIGNED TO EXAMINER

07/15/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/08/2013

NWAP

NEW APPLICATION ENTERED

04/04/2013

Continuous trademark protection

Get notified about every new filing that threatens PLEXISION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.